Connection

NIDHI SAHNI to Humans

This is a "connection" page, showing publications NIDHI SAHNI has written about Humans.
Connection Strength

0.302
  1. UBA1 inhibition sensitizes cancer cells to PARP inhibitors. Cell Rep Med. 2024 Dec 17; 5(12):101834.
    View in: PubMed
    Score: 0.019
  2. PRMT blockade induces defective DNA replication stress response and synergizes with PARP inhibition. Cell Rep Med. 2023 12 19; 4(12):101326.
    View in: PubMed
    Score: 0.018
  3. Widespread BRCA1/2-independent homologous recombination defects are caused by alterations in RNA-binding proteins. Cell Rep Med. 2023 11 21; 4(11):101255.
    View in: PubMed
    Score: 0.018
  4. Biomolecular Condensation: A New Phase in Cancer Research. Cancer Discov. 2022 09 02; 12(9):2031-2043.
    View in: PubMed
    Score: 0.016
  5. MERIT: Systematic Analysis and Characterization of Mutational Effect on RNA Interactome Topology. Hepatology. 2019 08; 70(2):532-546.
    View in: PubMed
    Score: 0.013
  6. Pathway perturbations in signaling networks: Linking genotype to phenotype. Semin Cell Dev Biol. 2020 03; 99:3-11.
    View in: PubMed
    Score: 0.012
  7. Multi-omics analysis reveals neoantigen-independent immune cell infiltration in copy-number driven cancers. Nat Commun. 2018 04 03; 9(1):1317.
    View in: PubMed
    Score: 0.012
  8. Base-resolution stratification of cancer mutations using functional variomics. Nat Protoc. 2017 Nov; 12(11):2323-2341.
    View in: PubMed
    Score: 0.012
  9. Regulome networks and mutational landscape in liver cancer: An informative path to precision medicine. Hepatology. 2017 07; 66(1):280-282.
    View in: PubMed
    Score: 0.011
  10. Functional variomics and network perturbation: connecting genotype to phenotype in cancer. Nat Rev Genet. 2017 07; 18(7):395-410.
    View in: PubMed
    Score: 0.011
  11. Signal Transduction and Regulation: Insights into Evolution. Biomed Res Int. 2016; 2016:8604245.
    View in: PubMed
    Score: 0.011
  12. Edgotype: a fundamental link between genotype and phenotype. Curr Opin Genet Dev. 2013 Dec; 23(6):649-57.
    View in: PubMed
    Score: 0.009
  13. Uncovering cell-type-specific immunomodulatory variants and molecular phenotypes in COVID-19 using structurally resolved protein networks. Cell Rep. 2024 Nov 26; 43(11):114930.
    View in: PubMed
    Score: 0.005
  14. Pervasive mislocalization of pathogenic coding variants underlying human disorders. Cell. 2024 Nov 14; 187(23):6725-6741.e13.
    View in: PubMed
    Score: 0.005
  15. Rapid iPSC inclusionopathy models shed light on formation, consequence, and molecular subtype of a-synuclein inclusions. Neuron. 2024 Sep 04; 112(17):2886-2909.e16.
    View in: PubMed
    Score: 0.005
  16. Population-level comparisons of gene regulatory networks modeled on high-throughput single-cell transcriptomics data. Nat Comput Sci. 2024 Mar; 4(3):237-250.
    View in: PubMed
    Score: 0.005
  17. Integrated multi-omics analyses identify anti-viral host factors and pathways controlling SARS-CoV-2 infection. Nat Commun. 2024 01 02; 15(1):109.
    View in: PubMed
    Score: 0.004
  18. Defining the condensate landscape of fusion oncoproteins. Nat Commun. 2023 09 28; 14(1):6008.
    View in: PubMed
    Score: 0.004
  19. Multiomics analyses reveal DARS1-AS1/YBX1-controlled posttranscriptional circuits promoting glioblastoma tumorigenesis/radioresistance. Sci Adv. 2023 08 04; 9(31):eadf3984.
    View in: PubMed
    Score: 0.004
  20. Alternative splicing of GSDMB modulates killer lymphocyte-triggered pyroptosis. Sci Immunol. 2023 04 28; 8(82):eadg3196.
    View in: PubMed
    Score: 0.004
  21. AD-Syn-Net: systematic identification of Alzheimer's disease-associated mutation and co-mutation vulnerabilities via deep learning. Brief Bioinform. 2023 03 19; 24(2).
    View in: PubMed
    Score: 0.004
  22. Landscape of MicroRNA Regulatory Network Architecture and Functional Rerouting in Cancer. Cancer Res. 2023 01 04; 83(1):59-73.
    View in: PubMed
    Score: 0.004
  23. BET inhibition induces vulnerability to MCL1 targeting through upregulation of fatty acid synthesis pathway in breast cancer. Cell Rep. 2022 09 13; 40(11):111304.
    View in: PubMed
    Score: 0.004
  24. A network-based approach to identify expression modules underlying rejection in pediatric liver transplantation. Cell Rep Med. 2022 04 19; 3(4):100605.
    View in: PubMed
    Score: 0.004
  25. A functional genomic approach to actionable gene fusions for precision oncology. Sci Adv. 2022 02 11; 8(6):eabm2382.
    View in: PubMed
    Score: 0.004
  26. mi-IsoNet: systems-scale microRNA landscape reveals rampant isoform-mediated gain of target interaction diversity and signaling specificity. Brief Bioinform. 2021 09 02; 22(5).
    View in: PubMed
    Score: 0.004
  27. An expanded universe of cancer targets. Cell. 2021 03 04; 184(5):1142-1155.
    View in: PubMed
    Score: 0.004
  28. e-MutPath: computational modeling reveals the functional landscape of genetic mutations rewiring interactome networks. Nucleic Acids Res. 2021 01 11; 49(1):e2.
    View in: PubMed
    Score: 0.004
  29. Integrated Genomic Characterization of the Human Immunome in Cancer. Cancer Res. 2020 11 01; 80(21):4854-4867.
    View in: PubMed
    Score: 0.004
  30. PBRM1 loss defines a nonimmunogenic tumor phenotype associated with checkpoint inhibitor resistance in renal carcinoma. Nat Commun. 2020 05 01; 11(1):2135.
    View in: PubMed
    Score: 0.003
  31. Cellular origins and genetic landscape of cutaneous gamma delta T cell lymphomas. Nat Commun. 2020 04 14; 11(1):1806.
    View in: PubMed
    Score: 0.003
  32. Proteome Instability Is a Therapeutic Vulnerability in Mismatch Repair-Deficient Cancer. Cancer Cell. 2020 03 16; 37(3):371-386.e12.
    View in: PubMed
    Score: 0.003
  33. Sequential Therapy with PARP and WEE1 Inhibitors Minimizes Toxicity while Maintaining Efficacy. Cancer Cell. 2019 06 10; 35(6):851-867.e7.
    View in: PubMed
    Score: 0.003
  34. FACER: comprehensive molecular and functional characterization of epigenetic chromatin regulators. Nucleic Acids Res. 2018 11 02; 46(19):10019-10033.
    View in: PubMed
    Score: 0.003
  35. Neomorphic PDGFRA extracellular domain driver mutations are resistant to PDGFRA targeted therapies. Nat Commun. 2018 11 02; 9(1):4583.
    View in: PubMed
    Score: 0.003
  36. Gene Regulatory Network Perturbation by Genetic and Epigenetic Variation. Trends Biochem Sci. 2018 08; 43(8):576-592.
    View in: PubMed
    Score: 0.003
  37. Systematic Functional Annotation of Somatic Mutations in Cancer. Cancer Cell. 2018 03 12; 33(3):450-462.e10.
    View in: PubMed
    Score: 0.003
  38. LncMAP: Pan-cancer atlas of long noncoding RNA-mediated transcriptional network perturbations. Nucleic Acids Res. 2018 02 16; 46(3):1113-1123.
    View in: PubMed
    Score: 0.003
  39. Revealing the Determinants of Widespread Alternative Splicing Perturbation in Cancer. Cell Rep. 2017 Oct 17; 21(3):798-812.
    View in: PubMed
    Score: 0.003
  40. HSP90 Shapes the Consequences of Human Genetic Variation. Cell. 2017 Feb 23; 168(5):856-866.e12.
    View in: PubMed
    Score: 0.003
  41. In Situ Peroxidase Labeling and Mass-Spectrometry Connects Alpha-Synuclein Directly to Endocytic Trafficking and mRNA Metabolism in Neurons. Cell Syst. 2017 02 22; 4(2):242-250.e4.
    View in: PubMed
    Score: 0.003
  42. Comparative analysis of protein interactome networks prioritizes candidate genes with cancer signatures. Oncotarget. 2016 Nov 29; 7(48):78841-78849.
    View in: PubMed
    Score: 0.003
  43. Multi-OMICs and Genome Editing Perspectives on Liver Cancer Signaling Networks. Biomed Res Int. 2016; 2016:6186281.
    View in: PubMed
    Score: 0.003
  44. Pooled-matrix protein interaction screens using Barcode Fusion Genetics. Mol Syst Biol. 2016 Apr 22; 12(4):863.
    View in: PubMed
    Score: 0.003
  45. Survey of variation in human transcription factors reveals prevalent DNA binding changes. Science. 2016 Mar 25; 351(6280):1450-1454.
    View in: PubMed
    Score: 0.003
  46. An extended set of yeast-based functional assays accurately identifies human disease mutations. Genome Res. 2016 05; 26(5):670-80.
    View in: PubMed
    Score: 0.003
  47. Widespread Expansion of Protein Interaction Capabilities by Alternative Splicing. Cell. 2016 02 11; 164(4):805-17.
    View in: PubMed
    Score: 0.003
  48. Widespread macromolecular interaction perturbations in human genetic disorders. Cell. 2015 Apr 23; 161(3):647-660.
    View in: PubMed
    Score: 0.002
  49. Human gene-centered transcription factor networks for enhancers and disease variants. Cell. 2015 Apr 23; 161(3):661-673.
    View in: PubMed
    Score: 0.002
  50. A disease module in the interactome explains disease heterogeneity, drug response and captures novel pathways and genes in asthma. Hum Mol Genet. 2015 Jun 01; 24(11):3005-20.
    View in: PubMed
    Score: 0.002
  51. A proteome-scale map of the human interactome network. Cell. 2014 11 20; 159(5):1212-1226.
    View in: PubMed
    Score: 0.002
  52. Systematic screening reveals a role for BRCA1 in the response to transcription-associated DNA damage. Genes Dev. 2014 Sep 01; 28(17):1957-75.
    View in: PubMed
    Score: 0.002
  53. Systematic identification of pathological lamin A interactors. Mol Biol Cell. 2014 May; 25(9):1493-510.
    View in: PubMed
    Score: 0.002
  54. Alternative mating type configurations (a/a versus a/a or a/a) of Candida albicans result in alternative biofilms regulated by different pathways. PLoS Biol. 2011 Aug; 9(8):e1001117.
    View in: PubMed
    Score: 0.002
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.